J. Drouin-Ouellet, S. Lau, PL. Brattas, DR. Ottosson, K. Pircs, D. Grassi, LM. Collins, R. Vuono, A.Andersson SjOland, G. Westergren-Torsson, ,C. Graff, L. Minthon, H. Toresson, RA. Barker, J. Jakobsson and M. Parmar
Department of Experimental Medical Science, Wallenberg Neuroscience Center, Division of Neurobiology and Lund Stem Cell Center, Lund University, Sweden. John van Geest Centre for Brain Repair & Department of Neurology, Department of Clinical Neurosciences, University of Cambridge, Cambridge. Department of Experimental Medical Science, Unit of Lung Biology, Lund University Lund Sweden Karolinska Institutet, Dept NVS, Center for Alzheimer Research, Division for Neurogeriatrics, Sweden. Karolinska University Hospital, Dept of Geriatric Medicine, Stockholm Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Lund University, Sweden�?
Posters & Accepted Abstracts: Biochem Mol biol J
Direct conversion of adult human fibroblasts into mature and functional neurons, termed induced neurons (iNs) was achieved for the first time five years ago. This technology offers a shortcut for obtaining patient and disease specific neurons for disease modeling, drug screening and other biomedical applications. Despite their great promise, reprogramming roadblocks have prevented the generation of iNs at a sufficiently high yield from adult dermal fibroblasts, which has significantly limited the adoption of this technology. To overcome this, we have developed a new highly efficient dual promoter-based vector system that results in efficient co-delivery of the two reprogramming factors Brn2a and Ascl1 in combination with either neuron specific microRNAs or the inhibition of the RE1-silencing transcription factor (REST). Global gene expression analysis showed that while both strategies resulted in induction of a neuronal program and similar level of neural conversion, the inhibition of REST induces the expression of additional genes that are related to neuronal identity and function. Based in this, we developed an optimized one-step method to efficiently reprogram dermal fibroblasts from elderly individuals using a single vector system and demonstrate that it is possible to obtain iNs of high yield and purity from aged individuals, including Parkinson��?s disease patients. We are now evaluating the conversion capability of these skin fibroblasts and our preliminary results suggest that iN cells from sporadic PD patients reprogram in a similar fashion as that of healthy individuals and could thus serve as a tool to model intracellular pathological features associated with PD Janelle.Drouin-Ouellet@med.lu.se
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 